Development and external validation of prognostic models to predict sudden and pump-failure death in patients with HFrEF from PARADIGM-HF and ATMOSPHERE
CONCLUSION: We developed and validated models which separately predict SD and PFD in patients with HFrEF. These models may help clinicians and patients consider therapies targeted at these modes of death.TRIAL REGISTRATION NUMBER: PARADIGM-HF: ClinicalTrials.gov NCT01035255, ATMOSPHERE: ClinicalTrials.gov NCT00853658.PMID:34101002 | DOI:10.1007/s00392-021-01888-x
Source: Clinical Lung Cancer - Category: Cancer & Oncology Authors: Li Shen Brian L Claggett Pardeep S Jhund William T Abraham Akshay Suvas Desai Kenneth Dickstein Jianjian Gong Lars V K øber Marty P Lefkowitz Jean L Rouleau Victor C Shi Karl Swedberg Michael R Zile Scott D Solomon John J V McMurray Source Type: research
More News: Cancer | Cancer & Oncology | Cardiology | Chloride | Coronary Artery Bypass Graft | Enalapril | Heart | Heart Failure | Lung Cancer | Tekturna